tiprankstipranks
Trending News
More News >
AstraZeneca Pharma India Limited (IN:ASTRAZEN)
:ASTRAZEN
India Market

AstraZeneca Pharma India Limited (ASTRAZEN) Ratios

Compare
11 Followers

AstraZeneca Pharma India Limited Ratios

IN:ASTRAZEN's free cash flow for Q3 2025 was ₹0.44. For the 2025 fiscal year, IN:ASTRAZEN's free cash flow was decreased by ₹ and operating cash flow was ₹0.10. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
2.61 2.61 2.61 2.18 2.12
Quick Ratio
1.97 1.97 1.97 1.68 1.70
Cash Ratio
1.42 1.42 1.42 1.30 1.35
Solvency Ratio
0.48 0.48 0.48 0.29 0.23
Operating Cash Flow Ratio
0.08 0.08 0.08 0.15 0.30
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 -6.59 -4.82
Net Current Asset Value
₹ 1.44B₹ 5.67B₹ 5.67B₹ 4.39B₹ 3.60B
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 <0.01 0.01
Debt-to-Equity Ratio
<0.01 <0.01 <0.01 0.01 0.02
Debt-to-Capital Ratio
<0.01 <0.01 <0.01 0.01 0.02
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.51 1.51 1.51 1.67 1.67
Debt Service Coverage Ratio
148.04 148.04 148.04 -14.14 -3.98
Interest Coverage Ratio
142.86 142.86 372.82 149.26 85.75
Debt to Market Cap
0.00 0.00 0.00 >-0.01 >-0.01
Interest Debt Per Share
2.32 2.32 2.32 3.14 3.83
Net Debt to EBITDA
-2.42 -2.13 -2.13 -3.27 -4.36
Profitability Margins
Gross Profit Margin
48.03%48.03%48.03%54.37%55.63%
EBIT Margin
17.04%17.04%17.04%13.43%10.43%
EBITDA Margin
18.19%18.19%18.19%15.05%12.53%
Operating Profit Margin
13.23%13.23%34.53%9.42%10.11%
Pretax Profit Margin
16.95%16.95%16.95%13.37%10.31%
Net Profit Margin
12.47%12.47%12.47%9.90%7.65%
Continuous Operations Profit Margin
12.47%12.47%12.47%9.90%7.65%
Net Income Per EBT
73.57%73.57%73.57%74.04%74.18%
EBT Per EBIT
128.06%128.06%49.07%141.90%101.94%
Return on Assets (ROA)
9.69%14.98%14.98%10.08%7.19%
Return on Equity (ROE)
18.10%22.69%22.69%16.87%12.05%
Return on Capital Employed (ROCE)
18.62%23.78%62.06%15.73%15.55%
Return on Invested Capital (ROIC)
13.95%17.45%45.54%11.75%11.93%
Return on Tangible Assets
9.64%15.01%15.01%10.16%7.19%
Earnings Yield
1.08%1.24%1.24%1.22%0.97%
Efficiency Ratios
Receivables Turnover
7.65 7.65 8.46 8.48 9.38
Payables Turnover
3.43 3.43 3.43 2.01 1.88
Inventory Turnover
2.95 2.95 2.95 2.41 2.55
Fixed Asset Turnover
19.98 19.98 19.98 14.29 10.50
Asset Turnover
1.20 1.20 1.20 1.02 0.94
Working Capital Turnover Ratio
2.52 2.52 2.52 2.43 2.34
Cash Conversion Cycle
-24.62 64.71 60.15 13.02 -12.36
Days of Sales Outstanding
43.20 47.70 43.14 43.06 38.91
Days of Inventory Outstanding
159.87 123.54 123.54 151.69 143.18
Days of Payables Outstanding
227.69 106.54 106.54 181.73 194.46
Operating Cycle
203.07 171.24 166.69 194.75 182.09
Cash Flow Ratios
Operating Cash Flow Per Share
11.15 11.15 11.15 23.32 40.32
Free Cash Flow Per Share
6.84 6.84 6.84 19.91 36.47
CapEx Per Share
4.30 4.30 4.30 3.41 3.85
Free Cash Flow to Operating Cash Flow
0.61 0.61 0.61 0.85 0.90
Dividend Paid and CapEx Coverage Ratio
0.55 0.55 0.55 2.04 6.89
Capital Expenditure Coverage Ratio
2.59 2.59 2.59 6.84 10.48
Operating Cash Flow Coverage Ratio
6.07 6.07 6.07 8.08 11.68
Operating Cash Flow to Sales Ratio
0.02 0.02 0.02 0.06 0.13
Free Cash Flow Yield
0.72%0.13%0.13%0.61%1.43%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
80.50 80.50 80.50 81.90 103.57
Price-to-Sales (P/S) Ratio
10.04 10.04 10.04 8.11 7.92
Price-to-Book (P/B) Ratio
18.26 18.26 18.26 13.81 12.48
Price-to-Free Cash Flow (P/FCF) Ratio
759.88 759.88 759.88 163.37 69.97
Price-to-Operating Cash Flow Ratio
466.51 466.51 466.51 139.49 63.29
Price-to-Earnings Growth (PEG) Ratio
1.29 1.29 1.29 1.34 -3.05
Price-to-Fair Value
18.26 18.26 18.26 13.81 12.48
Enterprise Value Multiple
53.04 53.04 53.04 50.59 58.85
Enterprise Value
48.54B 125.01B 125.01B 76.39B 59.40B
EV to EBITDA
67.90 53.04 53.04 50.59 58.85
EV to Sales
6.67 9.65 9.65 7.62 7.37
EV to Free Cash Flow
133.76 730.60 730.60 153.46 65.14
EV to Operating Cash Flow
88.29 448.53 448.53 131.03 58.93
Tangible Book Value Per Share
283.92 283.92 283.92 235.48 204.56
Shareholders’ Equity Per Share
284.77 284.77 284.77 235.48 204.56
Tax and Other Ratios
Effective Tax Rate
0.26 0.26 0.26 0.26 0.26
Revenue Per Share
518.21 518.21 518.21 401.19 322.24
Net Income Per Share
64.60 64.60 64.60 39.72 24.64
Tax Burden
0.75 0.74 0.74 0.74 0.74
Interest Burden
1.28 0.99 0.99 1.00 0.99
Research & Development to Revenue
0.00 0.00 0.00 0.06 0.05
SG&A to Revenue
0.03 0.03 0.03 0.03 0.03
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
0.76 0.17 0.17 0.43 1.21
Currency in INR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis